The histone-methylating polycomb repressive complex 2 (PRC2) is an additional critical mediator of gene expression in MYCN-amplified neuroblastoma and inhibition of one of the complex members, enhancer of zeste homolog 2 (EZH2), has antitumor activity in some murine models (14–16). Here, EZH2 is linked to neuroblastoma.